NantKwest(NK)

合作开发通用实体瘤NK样细胞疗法，新锐B轮融资超5亿

医麦客2023-02-19 07:37

2023年2月19日/医麦客新闻 eMedClub News/--近日，临床阶段公司GAIA BioMedicine宣布和TreeFrog Therapeutics合作，利用TreeFrog 的C-Stem™技术大规模扩增针对实体瘤的同种异体NK样细胞，进而解决NK样细胞的供应难题。早在2021年，TreeFrog Therapeutics完成了7500万美元的B轮融资以推进C-Stem:...查看全文

资本主义拉美行不通2022-05-11 09:16

回复@进雪球做方丈: 制造业占比高的国家，你可以拉个清单看看都是些什么国家。Industry (including construction), value added (% of GDP) | Data (worldbank.org){Industry (including construction), value added (% of GDP) | Data (worldbank.org)}
网页链接查看全文

$NantKwest, Inc.(NK)$ 内部交易: 2018-05-16,Director,GORLIN STEVE ,卖出,16200普通股, $4.05

$NantKwest, Inc.(NK)$ 内部交易: 2018-05-15,Director,GORLIN STEVE ,卖出,26835普通股, $4.13

$NantKwest, Inc.(NK)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-07 AccNo: 0001564590-18-011240 Size: 8 MB 网页链接

$NantKwest, Inc.(NK)$ DEF 14A - Other definitive proxy statements Filed: 2018-04-24 AccNo: 0001193125-18-128761 Size: 812 KB 网页链接

$NantKwest, Inc.(NK)$ 8-K - Current report Filed: 2018-04-17 AccNo: 0001193125-18-119869 Size: 14 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接

$NantKwest, Inc.(NK)$ 内部交易: 2018-03-23,Chief Accounting Officer,Nelson Sonja ,期权,15000普通股, $0.00

$NantKwest, Inc.(NK)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-03-12 AccNo: 0001564590-18-005290 Size: 19 MB 网页链接

$NantKwest, Inc.(NK)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-13 AccNo: 0001193125-18-042675 Size: 34 KB 网页链接

$NantKwest, Inc.(NK)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-13 AccNo: 0000903423-18-000084 Size: 89 KB 网页链接

$NantKwest, Inc.(NK)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-11-07 AccNo: 0001564590-17-022217 Size: 9 MB 网页链接